COMPASS Pathways PLC Sponsored ADR (CMPS) vs Starling Oncology, Inc. (STLN)
- COMPASS Pathways PLC Sponsored ADR CMPS 8.59 +9.99%
- Starling Oncology, Inc. STLN 3.51 −47.61%
COMPASS Pathways PLC Sponsored ADR and Starling Oncology, Inc. are both Medical Care Facilities companies. COMPASS Pathways PLC Sponsored ADR is the larger, with a market value of $1.1B against $669.9M — 1.7× the size. COMPASS Pathways PLC Sponsored ADR has the higher net margin (0.00% vs −5.73%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Starling Oncology, Inc. leads on 8 and COMPASS Pathways PLC Sponsored ADR on 3.
Valuation
Profitability
| Metric | CMPS | STLN | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | — | 0.00% | 30.56% |
| Operating margin | 0.00% | (3.39%) | 6.62% |
| Net margin | 0.00% | (5.73%) | 3.08% |
| Free cash flow margin | 0.00% | 3.03% | 7.22% |
| Return on equity | (311.56%) | 143.21% | 6.41% |
| Return on assets | (72.25%) | (20.23%) | 2.78% |
| Return on invested capital | 0.00% | 0.00% | 7.44% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack